607 related articles for article (PubMed ID: 20472501)
1. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
; Key TJ; Appleby PN; Reeves GK; Roddam AW
Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study.
Adachi Y; Nojima M; Mori M; Himori R; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A;
Cancer Prev Res (Phila); 2020 Apr; 13(4):385-394. PubMed ID: 31996369
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.
Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A;
Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841
[TBL] [Abstract][Full Text] [Related]
4. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
[TBL] [Abstract][Full Text] [Related]
5. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
6. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.
Adachi Y; Nojima M; Mori M; Yamashita K; Yamano HO; Nakase H; Endo T; Wakai K; Sakata K; Tamakoshi A
World J Gastroenterol; 2017 May; 23(19):3488-3495. PubMed ID: 28596684
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
9. Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors.
Adachi Y; Nojima M; Mori M; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A;
J Gastroenterol Hepatol; 2019 Dec; 34(12):2104-2111. PubMed ID: 31158304
[TBL] [Abstract][Full Text] [Related]
10. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
[TBL] [Abstract][Full Text] [Related]
11. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.
Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI
Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Rinaldi S; Landi S; Boillot C; Monnier S; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Ardanaz E; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Br J Cancer; 2006 Jan; 94(2):299-307. PubMed ID: 16404426
[TBL] [Abstract][Full Text] [Related]
14. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
[TBL] [Abstract][Full Text] [Related]
16. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
17. Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study.
Wu MH; Chou YC; Chou WY; Hsu GC; Chu CH; Yu CP; Yu JC; Sun CA
Int J Cancer; 2010 Jan; 126(2):508-14. PubMed ID: 19585556
[TBL] [Abstract][Full Text] [Related]
18. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.
Chen W; Wang S; Tian T; Bai J; Hu Z; Xu Y; Dong J; Chen F; Wang X; Shen H
Eur J Hum Genet; 2009 Dec; 17(12):1668-75. PubMed ID: 19491931
[TBL] [Abstract][Full Text] [Related]
19. IGF1 and risk of additional breast cancer in the WHEL study.
Al-Delaimy WK; Flatt SW; Natarajan L; Laughlin GA; Rock CL; Gold EB; Caan BJ; Parker BA; Pierce JP
Endocr Relat Cancer; 2011 Apr; 18(2):235-44. PubMed ID: 21263044
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]